Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Servier
Pharma
JPM25: Servier chief on 'staying authentic' as firm grows reach
Six years on, Servier’s U.S. arm has made good on its oncology ambitions, while managing to stay true to its patient-centric ethos along the way.
Fraiser Kansteiner
Jan 23, 2025 1:00pm
In a first, FDA approves Servier's Voranigo in low-grade gliomas
Aug 6, 2024 5:25pm
AstraZeneca climbs cancer reputation ranking to take 2nd spot
Jun 11, 2024 7:30am
New name takes top spot in US patient group reputation ranking
May 14, 2024 10:54am
Court reverses Servier verdict, orders payment of €430M
Dec 21, 2023 11:41am
Patients name US' most reputable pharma, ax Pfizer from top 3
May 10, 2023 8:40am